Agios Pharmaceuticals AGIO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.75M+3.9% | $19.97M+55.0% | $12.88M+3.4% | $12.46M+42.7% | $8.73M-18.7% | ||
| $1.32M-29.8% | $1.88M+11.9% | $1.68M-1.4% | $1.7M+56.9% | $1.09M-13.9% | ||
| $19.43M+7.4% | $18.09M+61.5% | $11.2M+4.2% | $10.75M+40.7% | $7.64M-19.3% | ||
| 93.6%+3.1pp | 90.6%+3.6pp | 87%+0.6pp | 86.3%-1.2pp | 87.6%-0.7pp | ||
| $81.15M-7.8% | $88.06M+1.5% | $86.8M-5.6% | $91.94M+26.4% | $72.74M-12.2% | ||
| $48.3M-6.4% | $51.61M+25.0% | $41.27M-10.0% | $45.87M+10.5% | $41.53M-19.7% | ||
| $130.77M-7.6% | $141.55M+9.1% | $129.75M-7.0% | $139.51M+20.9% | $115.36M-15.0% | ||
| -$110.03M+9.5% | -$121.58M-4.0% | -$116.87M+8.0% | -$127.06M-19.2% | -$106.63M+14.7% | ||
| -530.3%+78.6pp | -608.9%+298pp | -907.4%+113pp | -1,020.1%+202pp | -1,222%-56.7pp | ||
| $10.8M-13.0% | $12.41M-7.2% | $13.37M-7.9% | $14.51M-9.8% | $16.09M-10.7% | ||
| $119K+5.3% | $113K+68.7% | $67K-87.2% | $523K-58.3% | $1.25M-22.8% | ||
| -$99.11M+8.3% | -$108.04M-4.5% | -$103.43M+7.7% | -$112.02M-25.5% | -$89.29M— | ||
| -477.7%+63.4pp | -541.1%+262pp | -803.1%+96.3pp | -899.4%+124pp | -1,023.3%— | ||
| -$1.69+8.6% | -$1.85-3.9% | -$1.78+7.8% | -$1.93-24.5% | -$1.55— | ||
| -$108.66M+9.7% | -$120.31M-4.2% | -$115.5M+8.2% | -$125.8M-19.4% | -$105.35M+14.8% | ||
| -523.8%+78.8pp | -602.6%+294pp | -896.7%+113pp | -1,010%+197pp | -1,207.3%-54.8pp | ||
| -$110.03M+9.5% | -$121.58M-4.0% | -$116.87M+8.0% | -$127.06M-19.2% | -$106.63M+14.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Agios Pharmaceuticals's revenue?
- Agios Pharmaceuticals (AGIO) generated $66.0M in revenue over the trailing twelve months, up 78.3% year over year.
- Is Agios Pharmaceuticals profitable?
- Agios Pharmaceuticals is not currently profitable: it reported a net loss of $422.6M over the trailing twelve months, a -639.8% net margin.
- What are Agios Pharmaceuticals's profit margins?
- Gross margin is 90.0% and operating margin is -720.0%, with a -639.8% net margin.
- What is Agios Pharmaceuticals's earnings per share?
- Agios Pharmaceuticals's diluted EPS over the trailing twelve months is $-7.25.
- Where does Agios Pharmaceuticals's income statement data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
